Which hedge funds own ABUS? ARBUTUS BIOPHARMA CORP, Q2 2026 13F holders
27 tracked hedge funds disclosed a position in ABUS (ARBUTUS BIOPHARMA CORP) in their Q2 2026 13F filings, worth $258.1m in total. The largest holder by portfolio weight is Whitefort Capital Management, LP at 18.7% of its book. 7 opened a new position this quarter: CenterBook Partners LP, Gsa Capital Partners LLP, Squarepoint Ops LLC, Voleon Capital Management LP. 7 exited: Avidity Partners Management LP, Adage Capital Partners GP, L.L.C., Prelude Capital Management, LLC.
- 27
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 7
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 7
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $7.0m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $16.3m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $258m
- Combined value Sum of the holders' reported positions in the security.
- 2.2%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Avidity Partners Management LP | 0.1% | $563k |
| Adage Capital Partners GP, L.L.C. | 0.02% | $12.0m |
| Prelude Capital Management, LLC | 0.01% | $114k |
| Millennium Management LLC | 0.0% | $2.9m |
| Balyasny Asset Management L.P. | 0.0% | $565k |
| ExodusPoint Capital Management, LP | 0.0% | $106k |
| Freestone Grove Partners LP | 0.0% | $81.0k |
Ownership over time
Who discovered ABUS first? Beta
The run: Q1 2020 → Q3 2021, +325%
| Whitefort Capital Management, LP high conviction | Q1 2023 | – | +13.2 pts |
| RTW Investments, LP high conviction | Q2 2017 | 0.3% | +2.2 pts |
| QVT Financial LP | Q3 2015 | – | +0.4 pts |
| Think Investments LP | Q3 2020 | – | +0.2 pts |
| Armistice Capital, LLC | Q3 2016 | – | −0.1 pts |
| Sabby Management, LLC | Q3 2015 | – | −0.5 pts |
| Alpha Wave Global, LP | Q3 2015 | – | −0.6 pts |
| EcoR1 Capital, LLC | Q3 2018 | – | −0.8 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.